- Home
- LAC vs RZLT Comparison
LAC vs RZLT Comparison
Compare LAC & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAC
- RZLT
- Stock Information
- Founded
- LAC 2023
- RZLT 2010
- Country
- LAC Canada
- RZLT United States
- Employees
- LAC N/A
- RZLT N/A
- Industry
- LAC Metal Mining
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- LAC Basic Materials
- RZLT Health Care
- Exchange
- LAC Nasdaq
- RZLT Nasdaq
- Market Cap
- LAC 722.6M
- RZLT 626.4M
- IPO Year
- LAC N/A
- RZLT N/A
- Fundamental
- Price
- LAC $2.85
- RZLT $7.97
- Analyst Decision
- LAC Buy
- RZLT Strong Buy
- Analyst Count
- LAC 4
- RZLT 5
- Target Price
- LAC $4.06
- RZLT $12.50
- AVG Volume (30 Days)
- LAC 6.0M
- RZLT 842.7K
- Earning Date
- LAC 11-06-2025
- RZLT 11-06-2025
- Dividend Yield
- LAC N/A
- RZLT N/A
- EPS Growth
- LAC N/A
- RZLT N/A
- EPS
- LAC N/A
- RZLT N/A
- Revenue
- LAC N/A
- RZLT N/A
- Revenue This Year
- LAC N/A
- RZLT N/A
- Revenue Next Year
- LAC N/A
- RZLT N/A
- P/E Ratio
- LAC N/A
- RZLT N/A
- Revenue Growth
- LAC N/A
- RZLT N/A
- 52 Week Low
- LAC $2.28
- RZLT $2.22
- 52 Week High
- LAC $5.20
- RZLT $8.34
- Technical
- Relative Strength Index (RSI)
- LAC 49.50
- RZLT 78.07
- Support Level
- LAC $2.74
- RZLT $6.92
- Resistance Level
- LAC $3.02
- RZLT $8.34
- Average True Range (ATR)
- LAC 0.13
- RZLT 0.32
- MACD
- LAC -0.01
- RZLT 0.05
- Stochastic Oscillator
- LAC 37.10
- RZLT 74.72
About LAC Lithium Americas Corp.
Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, which is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass is under construction and expected to begin production in 2028. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.